People · Operator
Named in public records as an officer, director or promoter · active 2020–2024 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aligned Exteriors Group LLC | — | Other | Series B | $23.0M | $127.4M | 2024 |
| Koligo Therapeutics, Inc. | — | Biotechnology | Seed | $3.6M | $64.2M | 2020 |
Matthew Lehman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Matthew Lehman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Paul Finnegan | 1 | 11 |
| Alexander Study | 1 | 2 |
| Jacob Meister | 1 | 2 |
| Michael B Hughes | 1 | 2 |
| Michael Wolsky | 1 | 1 |
| Eric Van Dam | 1 | 1 |
| Stuart B Williams | 1 | 1 |
| Matthew B Lehman | 1 | 1 |
| Balamurugan B Appakalai | 1 | 1 |
| David B Blanford | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.